"In terms of association with climate, our results suggest a relationship between enhancing lesions and tropical nights, a variable indicating extreme temperatures, which had not been previously ...

Please provide your email address to receive an email when new articles are posted on . Patients with MS who had higher energy-adjusted Dietary Inflammatory Index scores were more than twice as likely ...

Clinical outcomes from routine practice confirm ocrelizumab effectiveness in relapsing MS, with low rates of disability worsening over 4 years.

Patients ages 50 or older with non-active multiple sclerosis (MS) who discontinued high-efficacy therapy (HET) had a higher risk of relapse compared with those who continued HET, a matched ...

Emerging science is shaking up what has been previously known about multiple sclerosis (MS), changing our understanding of the basic biology of the disease. For years, the classical picture of MS has ...

Relapsing-remitting multiple sclerosis (MS) is commonly treated with parenteral drugs that can lead to adverse events and poor adherence. Three phase 3 randomized trials evaluated the efficacy and ...

Please provide your email address to receive an email when new articles are posted on . WEST PALM BEACH, Fla. — Spinal cord atrophy appeared to predict silent progression in relapse-onset MS, ...

A blood test that measures elevations in neurofilament light chain (NfL) levels in patients with multiple sclerosis (MS) could warn of worsening disability up to 2 years before it occurs, a new study ...

Machine learning can help predict whether people newly diagnosed with MS will experience disability worsening that occurs ...

The Elliot's Neurological Specialties clinic combines medical treatments to slow MS progression with holistic approaches to ...